Clinical trial · Interventional
Impact of the Oral Microbiota on Relapse in HNSCC Patients
NCT06807034CI-TRIAL-00085469MICR-ORLactive not recruitingPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
to characterise the impact of microbiota in radiotherapy efficacy
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| buccal swabs | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- buccal swabs
- description
- buccal swabs for microbiota analysis before and after treatment
- interventionNames
- Other: buccal swabs
Primary outcomes (1)
- measure
- Microbiota
- timeFrame
- 2 years
- description
- Analysis of buccal microbiota by 16SrRNA gene sequencing
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * head and neck cancer Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.